Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts
Open Access
- 16 October 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (10), e7475
- https://doi.org/10.1371/journal.pone.0007475
Abstract
The processes that drive fibrotic diseases are complex and include an influx of peripheral blood monocytes that can differentiate into fibroblast-like cells called fibrocytes. Monocytes can also differentiate into other cell types, such as tissue macrophages. The ability to discriminate between monocytes, macrophages, fibrocytes, and fibroblasts in fibrotic lesions could be beneficial in identifying therapies that target either stromal fibroblasts or fibrocytes. We have identified markers that discriminate between human peripheral blood monocytes, tissue macrophages, fibrocytes, and fibroblasts. Amongst these four cell types, only peripheral blood monocytes express the combination of CD45RO, CD93, and S100A8/A9; only macrophages express the combination of CD45RO, 25F9, S100A8/A9, and PM-2K; only fibrocytes express the combination of CD45RO, 25F9, and S100A8/A9, but not PM-2K; and only fibroblasts express the combination of CD90, cellular fibronectin, hyaluronan, and TE-7. These markers are effective both in vitro and in sections from human lung. We found that markers such as CD34, CD68, and collagen do not effectively discriminate between the four cell types. In addition, IL-4, IL-12, IL-13, IFN-γ, and SAP differentially regulate the expression of CD32, CD163, CD172a, and CD206 on both macrophages and fibrocytes. Finally, CD49c (α3 integrin) expression identifies a subset of fibrocytes, and this subset increases with time in culture. These results suggest that discrimination of monocytes, macrophages, fibrocytes, and fibroblasts in fibrotic lesions is possible, and this may allow for an assessment of fibrocytes in fibrotic diseases.Keywords
This publication has 92 references indexed in Scilit:
- Tumor‐promoting phenotype of CD90hi prostate cancer‐associated fibroblastsThe Prostate, 2009
- Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiationJournal of Leukocyte Biology, 2008
- Serum amyloid P inhibits dermal wound healingWound Repair and Regeneration, 2008
- Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal FibrosisThe American Journal of Pathology, 2008
- Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancerInternational Journal of Cancer, 2007
- Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in miceProceedings of the National Academy of Sciences of the United States of America, 2006
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Cutaneous Wound HealingThe New England Journal of Medicine, 1999
- Interleukin‐2 receptor common γ‐chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti‐apoptotic (bcl‐2, bcl‐xL) but not pro‐apoptotic (bax, bcl‐xS) gene expressionEuropean Journal of Immunology, 1996